Search Results
Baxter Launches Zosyn Premix In US
Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.S. launch of ZOSYN (piperacillin and tazobactam) Injection. Zosyn premix is indicated for the treatment of multiple infections caused by susceptible bacteria and is available in Baxter’s proprietary single-dose Galaxy containers.
Baxter Showcases Surgical Innovations at AORN Global Surgical Conference and Expo 2023
Baxter International Inc. (NYSE:BAX), a leader in solutions to advance surgical innovation, unveiled multiple new additions to its surgical portfolios at the Association of periOperative Registered Nurses (AORN) Global Surgical Conference & Expo 2023, taking place April 1 through April 4, 2023.
Baxter to Host Annual Meeting of Stockholders in Virtual Format
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2023 Annual Meeting) in a virtual format on Tuesday, May 2, 2023 at 9 a.m., Central Time, as disclosed in Baxter’s proxy statement for the meeting. Online access to the meeting will begin at 8:30 a.m., Central Time. Stockholders will not be able to attend the meeting in person.
Turn Insights Into Action With Connected Medical Devices
As we strive to build digital health solutions that help streamline hospital operations and personalize patient care, we are collaborating with Amazon Web Services (AWS) to deliver actionable insights that can help clinicians make informed decisions.
Destined to Advocate for Diversity, Equity and Inclusion
Meet Rachel, co-president of our Alliance for Baxter Women business resource group
Cardiac Monitoring Patch Helps Mom’s Life Stay on Beat
Since she was a child, Lauryn—a Baxter sales executive—managed a cardiovascular condition that caused her heart to beat irregularly fast and took her away from the moments that mattered most. When she was prescribed and used the diagnostic product she sold, she obtained a precise diagnosis that led to a lasting treatment.
A Grassroots and Global Approach to a Business Resource Group
Meet Bruce, a territory manager for our Front Line Care business, and co-president of Baxter's Black Professional Alliance
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on April 3, 2023, to shareholders of record as of February 24, 2023. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter
Baxter Reports Fourth-Quarter and Full-Year 2022 Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2022, and provided its financial guidance for full-year and first-quarter 2023.
Baxter to Host Fourth-Quarter 2022 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2022 financial results on Thursday, February 9, 2023 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/EmxweYhQ to pre-register for the call and receive the call information.